Existing risk of bias assessment tools are primarily designed for traditional pairwise Meta-analysis and fail to comprehensively evaluate the unique sources of bias risk inherent in network Meta-analysis. Therefore, Lunny and others developed a tool the Risk of Bias in Network Meta-analysis (RoB NMA), designed specifically to evaluate potential biases in network Meta-analysis arising from aspects such as intervention selection and network structure, effect modifiers, and statistical analysis. This article aims to interpret the development background, item content, and evaluation process of the RoB NMA tool, providing reference and guidance for domestic researchers of its application.
HomeArticlesVol 35,2025 No.12Detail
An introduction to Risk of Bias in Network Meta-analysis (RoB NMA) tool
Published on Dec. 29, 2025Total Views: 11623 timesTotal Downloads: 1644 timesDownloadMobile
- Abstract
- Full-text
- References
Abstract
Full-text
References
1.Willis BH, Quigley M. The assessment of the quality of reporting of Meta-analyses in diagnostic research: a systematic review[J]. BMC Med Res Methodol, 2011, 11: 163. DOI: 10.1186/1471-2288-11-163.
2.Zhao H, Hodges JS, Ma H, et al. Hierarchical Bayesian approaches for detecting inconsistency in network Meta-analysis[J]. Stat Med, 2016, 35(20): 3524-3536. DOI: 10.1002/sim.6938.
3.Chaimani A, Caldwell DM, Li T, et al. Undertaking network Meta-analyses. Cochrane handbook for systematic reviews of interventions[EB/OL]. [2025-07-01]. DOI: 10.1002/9781119536604.ch11.
4.Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons[J]. Stat Med, 2004, 23(20): 3105-3124. DOI: 10.1002/sim.1875.
5.Mills EJ, Bansback N, Ghement I, et al. Multiple treatment comparison Meta-analyses: a step forward into complexity[J]. Clin Epidemiol, 2011, 3: 193-202. DOI: 10.2147/CLEP.S16526.
6.Mills EJ, Kanters S, Thorlund K, et al. The effects of excluding treatments from network Meta-analyses: survey[J]. BMJ, 2013, 347: f5195. DOI: 10.1136/bmj.f5195.
7.Bafeta A, Trinquart L, Seror R, et al. Reporting of results from network Meta-analyses: methodological systematic review[J]. BMJ, 2014, 348: g1741. DOI: 10.1136/bmj.g1741.
8.Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence[J]. BMJ, 2005, 331(7521): 897-900. DOI: 10.1136/bmj.331.7521.897.
9.Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network Meta-analysis[J]. BMJ, 2013, 346: f2914. DOI: 10.1136/bmj.f2914.
10.Li T, Puhan MA, Vedula SS, et al. Network Meta-analysis-highly attractive but more methodological research is needed[J]. BMC Med, 2011, 9: 79. DOI: 10.1186/1741-7015-9-79.
11.Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment Meta-analysis: an overview and tutorial[J]. J Clin Epidemiol, 2011, 64(2): 163-171. DOI: 10.1016/j.jclinepi.2010.03.016.
12.Brunström M, Thomopoulos C, Carlberg B, et al. Methodological aspects of Meta-analyses assessing the effect of blood pressure-lowering treatment on clinical outcomes[J]. Hypertension, 2022, 79(3): 491-504. DOI: 10.1161/HYPERTENSIONAHA.121.18413.
13.Whiting P, Savović J, Higgins JP, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed[J]. J Clin Epidemiol, 2016, 69: 225-234. DOI: 10.1016/j.jclinepi.2015.06.005.
14.Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. BMJ, 2017, 358: j4008. DOI: 10.1136/bmj.j4008.
15.吴琼芳, 丁泓帆, 邓围, 等. ROBIS:评估系统评价偏倚风险的新工具[J]. 中国循证医学杂志, 2015, 15(12): 1454-1457. [Wu QF, Ding HF, Deng W, et al. ROBIS: a new tool to assess risk of bias in systematic reviews[J]. Chinese Journal of Evidence-Based Medicine, 2015, 15(12): 1454-1457.] DOI: CNKI:SUN:ZZXZ.0.2015-12-013.
16.陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具AMSTAR 2解读[J]. 中国循证医学杂志, 2018, 18(1): 101-108. [Tao H, Yang LT, Ping A, et al. Interpretation of AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions[J]. Chinese Journal of Evidence-Based Medicine, 2018, 18(1): 101-108.] DOI: CNKI:SUN:ZZXZ.0.2018-01-017.
17.Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials[J]. BMJ, 2019, 366: l4898. DOI: 10.1136/bmj.l4898.
18.刘津池, 刘畅, 华成舸. 随机对照试验偏倚风险评价工具RoB2(2019修订版)解读[J]. 中国循证医学杂志, 2021, 21(6): 737-744. [Liu JC, Liu C, Hua CG. Risk bias assessment tool RoB2 (revised version 2019) for randomized controlled trial :an interpretation[J]. Chinese Journal of Evidence-Based Medicine, 2021, 21(6): 737-744.] DOI: 10.7507/1672-2531.202011144.
19.Page MJ, Sterne JAC, Boutron I, et al. ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with Meta-analysis[J]. BMJ, 2023, 383: e076754. DOI: 10.1136/bmj-2023-076754.
20.Chiocchia V, Nikolakopoulou A, Higgins JPT, et al. ROB-MEN: a tool to assess risk of bias due to missing evidence in network Meta-analysis[J]. BMC Med, 2021, 19(1): 304. DOI: 10.1186/s12916-021-02166-3.
21.邓湘金, 胡玉鹏, 高歌, 等. 不报告偏倚风险评价工具ROB-ME中文解读[J]. 中国循证医学杂志, 2023, 23(7): 843-848. [Deng XJ, Hu YP, Gao G, et al. Risk of bias due to missing evidence (ROB-ME): a Chinese interpretation[J].Chinese Journal of Evidence-Based Medicine, 2023, 23(7): 843-848.] DOI: 10.7507/1672-2531.202303107.
22.胡玉鹏, 朱涛, 邓湘金, 等. 网状Meta分析证据缺失偏倚风险评价工具ROB-MEN中文解读[J]. 中国循证医学杂志, 2024, 24(4): 451-458. [Hu YP, Zhu T, Deng XJ, et al. A Chinese introduction to risk of bias due to missing evidence in network Meta-analysis(ROB-MEN)[J]. Chinese Journal of Evidence-Based Medicine, 2024, 24(4): 451-458.] https://www.cnki.com.cn/Article/CJFDTotal-ZZXZ202404009.htm
23.Lunny C, Higgins JPT, White IR, et al. Risk of bias in network Meta-analysis (RoB NMA) tool[J]. BMJ, 2025, 388: e079839. DOI: 10.1136/bmj-2024-079839.
24.Karlsson WK, Ostinelli EG, Zhuang ZA, et al. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network Meta-analysis[J]. BMJ, 2024, 386: e080107. DOI: 10.1136/bmj-2024-080107.
Popular Papers
-
PROBAST+AI: an interpretation of the tool for assessing the quality, risk of bias and applicability of prediction models based on traditional or artificial intelligence methods
Aug. 04, 20264033
-
Trends in health literacy among older adults in China from 2012 to 2022: a cross-temporal Meta-analysis
Jun. 09, 20264006
-
Methodological advances and application in clinical research of nested case-control studies
Jun. 09, 20263945
-
Multidisciplinary team management of aneurysmal bone cyst in the jugular foramen: a case report and literature review
Jul. 02, 20263744
-
Circuit mechanism and network reorganization of electroencephalographic neurofeedback on emotional disorders
Jul. 02, 20263286
-
Impact of interactive devices in nursing on the motor ability of patients with ischemic stroke: a systematic review and Meta-analysis
Jun. 09, 20263215
-
Research on living clinical practice guidelines in diabetes mellitus Ⅲ: methodological characteristics analysis of recommendations classification and evidence grading in the Chinese clinical practice guidelines for type 2 diabetes mellitus
Jul. 02, 20263148
-
Incidence and risk factors of permanent stoma after temporary stoma in sphincter-preserving surgery for rectal cancer: a systematic review and Meta-analysis
Jul. 02, 20263145
-
Analysis of imaging characteristics of 24 MHz very high-frequency ultrasound in scalp examination of patients with androgenetic alopecia
Jul. 02, 20263085
-
Effects of different anesthesia methods on perioperative circulation and post-operative recovery in elderly patients with benign prostatic hyperplasia undergoing blue laser vaporization of the prostate
Jun. 09, 20263081
-
Recent advances in the diagnosis and treatment of neovascular glaucoma
Aug. 04, 20263071
-
Correlation between the expression of cell proliferation nuclear antigen Ki-67 and tumor-infiltrating lymphocytes in breast cancer: a systematic review and Me-ta-analysis
Jun. 09, 20262910
-
The impact of TGF-β1 on tumor immunity and the advances of targeted therapy
Jun. 09, 20262909
-
Research on the promotion of clinical practice guidelines implementation (Ⅸ): a framework design for computable formalization of diagnostic and therapeutic process knowledge and construction of knowledge praphs in clinical practice guidelines
Jun. 09, 20262763
-
Application value of blood lithium monitoring in relapse prediction of maintenance treatment for bipolar disorder
Jul. 02, 20262751
Welcome to visit Zhongnan Medical Journal Press Series journal website!